难治性肠易激综合征诊治的研究进展  

Recent Developments in the Diagnosis and Treatment of Refractory Irritable Bowel Syndrome

作　　者：谢欣 陈敏[1] 叶坤 赵俊 魏庆双 吴巧凤[2] 李志刚[3] 余曙光[2] XIE Xin;CHEN Min;YE Kun;ZHAO Jun;WEI Qingshuang;WU Qiaofeng;LI Zhigang;YU Shuguang(Clinical Medical College/Affiliated Hospital,Chengdu University of TCM,Chengdu 610075,China;School of Acupuncture-Moxibustion and Tuina,Chengdu University of TCM,Chengdu 610075,China;School of Acupuncture-Moxibustion and Tuina,Beijing University of Chinese Medicine,Beijing 100029,China)

机构地区：[1]成都中医药大学临床医学院/附属医院,四川省成都市610075 [2]成都中医药大学针灸推拿学院,四川省成都市610075 [3]北京中医药大学针灸推拿学院,北京市100029

出　　处：《中国全科医学》2021年第21期2640-2645,共6页Chinese General Practice

基　　金：国家重点研发计划“中医药现代化研究”重点专项(2019YFC1709004)。

摘　　要：肠易激综合征是临床常见的功能性胃肠病之一,病理机制复杂,临床采用单一治疗模式多难以奏效,部分患者病情迁延成为难治性肠易激综合征。目前国内外对难治性肠易激综合征并无准确定义和诊断标准,亦无统一的治疗方法。本文就目前国内外难治性肠易激综合征的诊断标准及治疗进展做一概述,以期为难治性肠易激综合征的临床诊治提供指导,使更多患者获益。Irritable bowel syndrome(IBS)is a functional gastrointestinal disorder that often seen in clinical practice.Monotherapy may not be effective for IBS due to its complex pathogenesis,as a result,some patients'condition is prolonged to become refractory.So far,there are no uniform definition,diagnostic criteria and treatments for refractory IBS.This article summarizes the diagnostic criteria and treatments for refractory IBS worldwide,which will contribute to its clinical diagnosis and treatment,benefiting more patients.

关 键 词：肠易激综合征 诊断 治疗 研究进展 

分 类 号：R574.62[医药卫生—消化系统]